SCHEMBL3779386

SCHEMBL3779386

C=CCCCC(CCCC=C)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC4 O15439 1/20 0.46
MAPT P10636 1/20 0.46
CHRM1 P11229 1/20 0.42
AKR1A1 P14550 1/20 0.42
CHRM3 P20309 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
ADRA1A P35348 1/20 0.42
HRH1 P35367 1/20 0.42
DRD3 P35462 1/20 0.42
SLC6A3 Q01959 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
FOLH1 Q04609 6/20 0.42
CA2 P00918 1/20 0.41
MAPK1 P28482 1/20 0.41
GRIK1 P39086 2/20 0.41
GRIK2 Q13002 2/20 0.41
CPA1 P15085 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5975672 0.96 MAPT (0.48) ABCC4MAPTCHRM1AKR1A1CHRM3
SCHEMBL5494036 0.96 ABCC4 (0.43) ABCC4MAPTCHRM1AKR1A1CHRM3
SCHEMBL4016679 0.93 MAPT (0.50) ABCC4MAPTCHRM1AKR1A1CHRM3
SCHEMBL7003560 0.92 ABCC4 (0.41) ABCC4MAPTCHRM1AKR1A1CHRM3
SCHEMBL3103111 0.91 MAPT (0.54) ABCC4MAPTCHRM1AKR1A1CHRM3
SCHEMBL21439803 0.91 MAPT (0.54) ABCC4MAPTCHRM1AKR1A1CHRM3
SCHEMBL10893905 0.91 MAPT (0.54) ABCC4MAPTCHRM1AKR1A1CHRM3
SCHEMBL4015850 0.91 MAPT (0.54) ABCC4MAPTCHRM1AKR1A1CHRM3
SCHEMBL3804921 0.91 MAPT (0.54) ABCC4MAPTCHRM1AKR1A1CHRM3
SCHEMBL27040201 0.91 MAPT (0.54) ABCC4MAPTCHRM1AKR1A1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504465-B2 Linear functional copolymers of ethylene with precise and minimum run length distributions and methods of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2009-03-17 US claimed
US-20080312393-A1 Linear functional copolymers of ethylene with precise and minimum run length distributions and methods of making thereof BAUGH LISA S 2008-12-18 US claimed
CN-1898279-A Linear functional copolymers of ethylene with precise and minimum run length distributions and methods of making thereof EXXONMOBIL RES & ENG CO (US) 2007-01-17 CN claimed
EP-1704172-A1 LINEAR FUNCTIONAL COPOLYMERS OF ETHYLENE WITH PRECISE AND MINIMUM RUN LENGTH DISTRIBUTIONS AND METHODS OF MAKING THEREOF ExxonMobil Research and Engineering Company (US) 2006-09-27 EP claimed
WO-2005063834-A1 LINEAR FUNCTIONAL COPOLYMERS OF ETHYLENE WITH PRECISE AND MINIMUM RUN LENGTH DISTRIBUTIONS AND METHODS OF MAKING THEREOF EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2005-07-14 WO claimed
US-20050137369-A1 Linear functional copolymers of ethylene with precise and minimum run length distributions and method of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2005-06-23 US claimed
WO-2025038855-A1 IONIZABLE LIPIDS WITH BRANCHED HEAD GROUPS BEAM THERAPEUTICS INC. (US) 2025-02-20 WO disclosed
US-20160068834-A1 STABLIZED EZH2 PEPTIDES DANA-FARBER CANCER INSTITUTE, INC. (US) 2016-03-10 US disclosed
US-20160046671-A1 STABILIZED SOS1 PEPTIDES DANA-FARBER CANCER INSTITUTE, INC. 2016-02-18 US disclosed
US-7858710-B2 Highly organized polyolefin structures UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2010-12-28 US disclosed
US-20090306319-A1 Highly Organized Polyolefin Structures UNIVERSITY OF FLORDIA RESEARCH FOUNDATION, INC. (US) 2009-12-10 US disclosed
US-7504465-B2 Linear functional copolymers of ethylene with precise and minimum run length distributions and methods of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2009-03-17 US disclosed
US-7504465-B2 Linear functional copolymers of ethylene with precise and minimum run length distributions and methods of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2009-03-17 US disclosed
US-7402642-B2 Linear functional copolymers of ethylene with precise and minimum run length distributions and method of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2008-07-22 US disclosed
US-7402642-B2 Linear functional copolymers of ethylene with precise and minimum run length distributions and method of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2008-07-22 US disclosed
WO-2007127690-A1 HIGHLY ORGANIZED POLYOLEFIN STRUCTURES UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2007-11-08 WO disclosed
CN-1898279-A Linear functional copolymers of ethylene with precise and minimum run length distributions and methods of making thereof EXXONMOBIL RES & ENG CO (US) 2007-01-17 CN disclosed
EP-1704172-A1 LINEAR FUNCTIONAL COPOLYMERS OF ETHYLENE WITH PRECISE AND MINIMUM RUN LENGTH DISTRIBUTIONS AND METHODS OF MAKING THEREOF ExxonMobil Research and Engineering Company (US) 2006-09-27 EP disclosed
WO-2005063834-A1 LINEAR FUNCTIONAL COPOLYMERS OF ETHYLENE WITH PRECISE AND MINIMUM RUN LENGTH DISTRIBUTIONS AND METHODS OF MAKING THEREOF EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2005-07-14 WO disclosed
US-20050137369-A1 Linear functional copolymers of ethylene with precise and minimum run length distributions and method of making thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160046671-A1 STABILIZED SOS1 PEPTIDES RASGRP1, KRAS, RASGRP3 ABCC4 3325/4885MAPT 3686/4885CHRM1 4472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.